Dr Gurdip Azad

Gurdip Azad completed her training in Clinical Oncology in the North of London, rotating between Mount Vernon Cancer Centre, North Middlesex Hospital, Royal Free Hospital, University College London Hospital and the Royal Marsden Hospital. She was appointed as a Consultant in Clinical Oncology at Guy’s and St Thomas’ Hospital in 2019. She completed her MD (Res) at King’s College London and was appointed as an Honorary Senior Clinical Lecturer in 2020 and an Adjunct Senior Lecturer in 2024.

Her main research interests are the role of molecular and functional imaging in primary and recurrent prostate cancers, the role of artificial intelligence in predicting prostate cancer recurrence, and many more. She specialises in CT based stereotactic radiotherapy and MR Linac based adaptive stereotactic radiotherapy to the prostate. She has presented her research in national and international conferences, published widely in peer reviewed journals and written chapters in text books. She received the Alavi-Mandell award for her publication in the Journal of Nuclear Medicine: “Does measurement of 18F-fluoride metabolic flux improve response assessment of breast cancer bone metastases compared with standardised uptake values in 18F-fluoride PET/CT?” Some of her publications include: Publications: 1) Book chapter on Radiotherapy and soft tissues. Annals of plastic surgery textbook by Ross D. Farhadieh, Neil Bulstrode, Sabrina Cugno. Published in 2022 2) Azad G, Siddique M, Taylor B, Green A, O'Doherty, J, Gariani J, Blake G, Mansi J, Goh V, Cook G. Reply to: Relevance of measurement uncertainty for quantitative response assessment of breast cancer bone metastases with 18F-fluoride. J Nucl Med. 2019 Apr;60(4):569 3) Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830 4) Azad G, Siddique M, Cousin F, Taylor B, Green A, O’Doherty J, Gariani J, Blake GM, Mansi J, Goh V, Cook J.R G. Does measurement of 18F-fluoride plasma clearance improve response assessment of breast cancer bone metastases compared with standardised uptake values in 18F-fluoride PET/CT? Journal of Nuclear Medicine . 2019 Journal of Nuclear Medicine, 60(3), 322-327